Alert: New Earnings Report (2/27/24)-Ligand Pharmaceuticals Inc (NASDAQ: LGND).
For its fourth fiscal quarter (ending December 31), Ligand Pharmaceuticals Inc (NASDAQ: LGND) has reported E.P.S. of $1.04 compared to $-0.86 a year ago. This performance was $0.38 better than the consensus estimate of $0.66. […]